CD36 and lip and oral cavity carcinoma: Recently, Sakurai et al. (2020) have demonstrated the role of CD36 in facilitating the proliferation and migration activity of OSCC cells, possibly by inhibiting β-catenin signaling pathway, and they emphasized its usefulness in the diagnosis of high-grade tumor and targeted therapy of oral cancer.